EF
MD icon

Empowered Funds’s Pediatrix Medical MD Stock Holding History

Empowered Funds’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7M Sell
500,118
-95,392
-16% -$2.17M 0.07% 323
2026
Q1 		$12.7M Sell
595,510
-26,870
-4% -$559K 0.08% 282
2025
Q4 		$13.3M Buy
622,380
+93,833
+18% +$1.92M 0.23% 89
2025
Q3 		$8.85M Buy
528,547
+42,966
+9% +$644K 0.09% 271
2025
Q2 		$6.97M Buy
485,581
+196,129
+68% +$2.69M 0.08% 335
2025
Q1 		$4.19M Buy
289,452
+9,007
+3% +$128K 0.06% 441
2024
Q4 		$3.68M Buy
280,445
+13,607
+5% +$188K 0.05% 476
2024
Q3 		$3.09M Buy
266,838
+13,534
+5% +$128K 0.05% 514
2024
Q2 		$1.91M Buy
253,304
+18,180
+8% +$150K 0.03% 627
2024
Q1 		$2.36M Buy
235,124
+17,784
+8% +$165K 0.04% 554
2023
Q4 		$2.02M Buy
+217,340
New +$2.25M 0.05% 513

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Empowered Funds's MD Position: Q2 2026 in Review

Empowered Funds reduced its Pediatrix Medical (MD) stake by 16% in Q2 2026, selling an estimated $2.17M and leaving 500,118 shares worth $12.7M. The position accounts for 0.07% of the portfolio, ranked #323.

Empowered Funds first reported a position in MD in Q4 2023 and has held it in 11 quarters since. The position peaked at $13.3M in Q4 2025. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Empowered Funds held 500,118 shares of Pediatrix Medical worth $12.7M as of Q2 2026.
  • Empowered Funds sold 95,392 Pediatrix Medical shares in Q2 2026, an estimated $2.17M.
  • Pediatrix Medical made up 0.07% of Empowered Funds's portfolio in Q2 2026, its #323 holding.
  • Empowered Funds first reported a position in Pediatrix Medical in Q4 2023 and has held it in 11 quarters since.
  • Empowered Funds's Pediatrix Medical position peaked at $13.3M in Q4 2025.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.